Noteworthy new products of the Congressional Research Service that have not been made readily available to the public include the following (all pdf).
“Defense: FY2008 Authorization and Appropriations,” updated September 17, 2007.
“Presidential Claims of Executive Privilege: History, Law, Practice and Recent Developments,” updated September 17, 2007.
“Arms Sales: Congressional Review Process,” updated September 12, 2007.
“Afghanistan: Post-War Governance, Security, and U.S. Policy,” updated September 10, 2007.
“Extraterritorial Application of American Criminal Law,” updated September 10, 2007.
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.